Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)

NCT01770145 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease
Motor Symptoms
Akinesia
Hypomobility
Delayed Levodopa Onset

Interventions

DRUG: APOKYN
DRUG: L-dopa
DRUG: Trimethobenzamide

Sponsor

MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals